| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 68083-101-02 | 68083-101 | HUMAN PRESCRIPTION DRUG | Adenosine | Adenosine | INJECTION | INTRAVENOUS | 20130401 | N/A | ANDA | ANDA077283 | Gland Pharma Limited | ADENOSINE | 3 mg/mL | 10 SYRINGE in 1 CARTON (68083-101-02) / 4 mL in 1 SYRINGE |
| 68083-101-01 | 68083-101 | HUMAN PRESCRIPTION DRUG | Adenosine | Adenosine | INJECTION | INTRAVENOUS | 20130401 | N/A | ANDA | ANDA077283 | Gland Pharma Limited | ADENOSINE | 3 mg/mL | 10 SYRINGE in 1 CARTON (68083-101-01) / 2 mL in 1 SYRINGE |
| 25021-301-68 | 25021-301 | HUMAN PRESCRIPTION DRUG | adenosine | adenosine | INJECTION | INTRAVENOUS | 20140416 | N/A | ANDA | ANDA077283 | Sagent Pharmaceuticals | ADENOSINE | 3 mg/mL | 10 SYRINGE in 1 CARTON (25021-301-68) / 4 mL in 1 SYRINGE |
| 25021-301-67 | 25021-301 | HUMAN PRESCRIPTION DRUG | adenosine | adenosine | INJECTION | INTRAVENOUS | 20140416 | N/A | ANDA | ANDA077283 | Sagent Pharmaceuticals | ADENOSINE | 3 mg/mL | 10 SYRINGE in 1 CARTON (25021-301-67) / 2 mL in 1 SYRINGE |
| 51662-1511-1 | 51662-1511 | HUMAN PRESCRIPTION DRUG | ADENOSINE | ADENOSINE | INJECTION | INTRAVENOUS | 20210121 | N/A | ANDA | ANDA077283 | HF Acquisition Co LLC, DBA HealthFirst | ADENOSINE | 3 mg/mL | 1 SYRINGE in 1 CARTON (51662-1511-1) / 4 mL in 1 SYRINGE |